help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hedman, C. A.
Right arrow Articles by Arnqvist, H. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hedman, C. A.
Right arrow Articles by Arnqvist, H. J
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 12 6305-6309
Copyright © 2004 by The Endocrine Society

Residual ß-Cell Function More than Glycemic Control Determines Abnormalities of the Insulin-Like Growth Factor System in Type 1 Diabetes

Christina A. Hedman, Jan Frystyk, Torbjörn Lindström, Jian-Wen Chen, Allan Flyvbjerg, Hans Ørskov and Hans J Arnqvist

Division of Internal Medicine (C.A.H., T.L., H.J.A.), Department of Medicine and Care and Division of Cell Biology (H.J.A.), Department of Biomedicine and Surgery, Diabetes Research Centre, Faculty of Health Sciences, Linkoping University, S-581 83 Linkoping, Sweden; and Medical Research Laboratories, Aarhus University Hospital (J.F., J.-W.C., A.F., H.Ø.), DK-8000 Aarhus, Denmark

Address all correspondence and requests for reprints to: Dr. Christina Hedman, Division of Internal Medicine, Department of Medicine and Care, Linkoping University, S-581 83 Linkoping, Sweden. E-mail: christina.hedman{at}lio.se.

The GH-IGF-I axis is disturbed in patients with type 1 diabetes. Our aim was to investigate whether abnormalities are found in patients in very good glycemic control and, if so, to estimate the role of residual ß-cell function. Patients with hemoglobin A1c (HbA1c) less than 6% (reference range, 3.6–5.4%) were selected for the study. Twenty-two men and 24 women, aged 41.3 ± 13.8 yr (mean ± SD), with a diabetes duration of 17.8 ± 14.6 yr participated. Healthy controls (15 women and nine men), aged 41.3 ± 13.0 yr, were also studied. Overnight fasting serum samples were analyzed for HbA1c, C peptide, free and total IGFs, IGF-binding proteins (IGFBPs), GH-binding protein, and IGFBP-3 proteolysis. HbA1c was 5.6 ± 0.5% in patients and 4.4 ± 0.3% in controls. Total IGF-I was 148 ± 7 µg/liter in patients and 178 ± 9 µg/liter in controls (P < 0.001). Free IGF-I, total IGF-II, IGFBP-3, and GH-binding protein were lower, whereas IGFBP-1, IGFBP-1-bound IGF-I, and IGFBP-2 were elevated compared with control values. Patients with detectable C peptide (≥100 pmol/liter) had higher levels of total IGF-I, free IGF-I, and total IGF-II and lower levels of IGFBP-1 and IGFBP-2 than those with an undetectable C peptide level despite having identical average HbA1c. IGFBP-3 proteolysis did not differ between patients and controls. Despite very good glycemic control, patients with type 1 diabetes and no endogenous insulin production have low free and total IGF-I. Residual ß-cell function, therefore, seems more important for the disturbances in the IGF system than good metabolic control per se, suggesting that portal insulin delivery is needed to normalize the IGF system.




This article has been cited by other articles:


Home page
Diabetes CareHome page
L. R. Nielsen, J. F. Rehfeld, U. Pedersen-Bjergaard, P. Damm, and E. R. Mathiesen
Pregnancy-Induced Rise in Serum C-Peptide Concentrations in Women With Type 1 Diabetes
Diabetes Care, June 1, 2009; 32(6): 1052 - 1057.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
N. Bjarnegard, H. J Arnqvist, T.;r. Lindstro;m, L. Jonasson, and T. Lanne
Long-term hyperglycaemia impairs vascular smooth muscle cell function in women with type 1 diabetes mellitus
Diabetes and Vascular Disease Research, January 1, 2009; 6(1): 25 - 31.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Frystyk, R. A. Ritzel, J. Maubach, M. Busing, R. Luck, J. Klempnauer, W. Schmiegel, and M. A. Nauck
Comparison of Pancreas-Transplanted Type 1 Diabetic Patients with Portal-Venous Versus Systemic-Venous Graft Drainage: Impact on Glucose Regulatory Hormones and the Growth Hormone/Insulin-Like Growth Factor-I Axis
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1758 - 1766.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. S. Johansson and H. J. Arnqvist
Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells
Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1124 - E1130.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Leger, D. Marinovic, C. Alberti, S. Dorgeret, D. Chevenne, C. L. Marchal, N. Tubiana-Rufi, G. Sebag, and P. Czernichow
Lower Bone Mineral Content in Children with Type 1 Diabetes Mellitus Is Linked to Female Sex, Low Insulin-Like Growth Factor Type I Levels, and High Insulin Requirement
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3947 - 3953.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
P. Rittler, B. Schiefer, H. Demmelmair, B. Koletzko, M. Vogeser, D. H. Alpers, K.-W. Jauch, and W. H. Hartl
The Effect of Hyperglycemic Hyperinsulinemia on Small-Intestinal Mucosal Protein Synthesis in Patients After Surgical Stress
JPEN J Parenter Enteral Nutr, March 1, 2006; 30(2): 97 - 107.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society